Journal of Shandong University (Health Sciences) ›› 2019, Vol. 57 ›› Issue (9): 69-73.doi: 10.6040/j.issn.1671-7554.0.2019.586

Previous Articles     Next Articles

Correlation between human gastric cancer mesenchymal stem cells and tumor progression in SGC-7901 tumor-bearing mice

ZHAO Hongjian1, ZHOU Jijun1, SU Qingliang1, ZHAO Shuo1, LI Yuming2   

  1. 1. Department of General Surgery, Chengwu Hospital, Qianfoshan Hospital Group, Chengwu 274200, Shandong, China;
    2. Department of Gastrointestinal Surgery, Binzhou Medical University Affiliated Hospital, Binzhou 256600, Shandong, China
  • Published:2022-09-27

Abstract: Objective To investigate the effects of human gastric cancer mesenchymal stem cells(hGC-MSCs)on the occurrence and development of gastric cancer cell line SGC-7901 in vivo. Methods The nude mice were divided into hGC-MSCs group, SGC-7901 group and hGC-MSCs+SGC-7901 group. The cell suspension was inoculated subcutaneously on the right back of the experimental mice to observe the occurrence of tumor, time of occurrence and change of tumor size. The expression levels of proliferating cell nuclear antigen(PCNA)and matrix metalloproteinase-9(MMP-9)were detected with immunohistochemical staining, real-time polymerase chain reaction(RT-PCR)and Western blotting. Results No tumor occurred in the control group. The hGC-MSCs+SGC-7901 group had shorter time of tumor occurrence, faster tumor growth and larger tumor size than the SGC-7901 group (P<0.05). The immunohistochemistry results showed that the average optical density of PCNA in SGC-7901 group and hGC-MSCs+SGC-7901 group was 0.358±0.009 and 0.481±0.030, respectively; the average optical density of MMP-9 in these two groups was 0.359±0.033 and 0.520±0.038, respectively (P<0.05). Real-time PCR demonstrated that hGC-MSCs could upregulate 山 东 大 学 学 报 (医 学 版)57卷9期 -赵鸿渐,等.胃癌间充质干细胞与SGC-7901荷瘤鼠肿瘤荷瘤鼠肿瘤进展的相关性研究 \=-the expressions of PCNA and MMP-9 (P<0.01). Western blotting showed that the PCNA protein band grayscale in SGC-7901 group and hGC-MSCs+SGC-7901 group was 0.756±0.039 and 0.847±0.048, respectively; the MMP-9 protein band grayscale in these two groups was 0.692±0.079 and 0.866±0.010, respectively (P<0.05). Conclusion HGC-MSCs participate in the occurrence and development of tumors by up-regulating the expression levels of PCNA and MMP-9 in vivo.

Key words: Gastric cancer, Mesenchymal stem cells, Proliferating cell nuclear antigen, Matrix metalloproteinase

CLC Number: 

  • R574
[1] Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2009[J]. CA Cancer J Clin, 2009, 59(4): 225-249.
[2] 张明凯, 李玉明, 蒋宏, 等. 人胃癌组织中间充质干细胞的生物学稳定性分析[J]. 中华临床医师杂志(电子版), 2012, 6(16): 4603-4606. ZHANG Mingkai, LI Yuming, JIANG Hong, et al. The biological stability characteristics of mesenchymal stem cells from human gastric cancer research[J]. Chin J Clin Electron Ed, 2012, 6(16): 4603-4606.
[3] Cao HL, Xu WR, Qian H, et al. Mesenchymal stem cell-like cells derived from human gastric cancer tissues[J]. Cancer Lett, 2009, 274(1): 61-71.
[4] 王凯, 李玉明, 张明凯, 等. 人胃癌组织中间充质干细胞对胃癌细胞株SGC-7901增殖与侵袭能力的影响[J]. 中华实验外科杂志, 2014, 31(3): 480-482. WANG Kai, LI Yuming, ZHANG Mingkai, et al. Effects of mesenchymal stem cells from human gastric cancer on proliferation and invasion of human gastric cancer cell strain SGC-7901[J]. Chin J Exp Surg, 2014, 31(3): 480-482.
[5] Han ZP, Jing YY, Zhang SS, et al. The role of immunosuppression of mesenchymal stem cells in tissue repair and tumor growth[J]. Cell Biosci, 2012, 2(1): 8.
[6] Ji RB, Zhang B, Zhang X, et al. Exosomes derived from human mesenchymal stem cells confer drug resistance in gastric cancer[J]. Cell Cycle, 2015, 14(15): 2473-2483.
[7] Cao HL, Xu WR, Qian H, et al. Mesenchymal stem cell-like cells derived from human gastric cancer tissues[J]. Cancer Lett, 2009, 274(1): 61-71.
[8] Wu CY, Wu MS, Chiang EP, et al. Plasma matrix metalloproteinase-9 level is better than serum matrix metalloproteinase-9 level to predict gastric cancer evolution[J]. Clin Cancer Res, 2007, 13(7): 2054-2060.
[9] 周烨, 朱慰祺. 增殖细胞核抗原与胃癌浸润、转移和预后的关系[J]. 实用癌症杂志, 1998, 13(3): 232-234.
[10] Doucette T, Rao G, Yang YH, et al. Mesenchymal stem cells display tumor-specific tropism in an RCAS/Ntv-a glioma model[J]. Neoplasia, 2011, 13(8): 716-725.
[11] Loebinger MR, Eddaoudi A, Davies D, et al. Mesenchymal stem cell delivery of TRAIL can eliminate metastatic cancer[J]. Cancer Res, 2009, 69(10): 4134-4142.
[12] 庞一琳, 张斌, 陈虎. 间充质干细胞与肿瘤细胞相互作用: 促进还是抑制[J]. 中华细胞与干细胞杂志(电子版), 2013, 3(1): 31-38.
[13] Tian LL, Yue WM, Zhu F, et al. Human mesenchymal stem cells play a dual role on tumor cell growth in vitro and in vivo[J]. J Cell Physiol, 2011, 226(7): 1860-1867.
[14] Ramasamy R, Lam EW, Soeiro I, et al. Mesenchymal stem cells inhibit proliferation and apoptosis of tumor cells: impact on in vivo tumor growth[J]. Leukemia, 2007, 21(2): 304-310.
[15] 李国才, 武金才, 孙冰生, 等. 骨髓间充质干细胞对人肝癌细胞系MHCC97-H增殖能力的影响[J]. 中华实验外科杂志, 2008, 25(7): 823-825. LI Guocai, WU Jincai, SUN Bingsheng, et al. The effect of mesenchymal stem cells on the proliferation of MHCC97-H cell fine[J]. Chin J Exp Surg, 2008, 25(7): 823-825.
[16] Ma Y, Hao XM, Zhang S, et al. The in vitro and in vivo effects of human umbilical cord mesenchymal stem cells on the growth of breast cancer cells[J]. Breast Cancer Res Treat, 2012, 133(2): 473-485.
[17] Klopp AH, Gupta A, Spaeth E, et al. Concise review: Dissecting a discrepancy in the literature: do mesenchymal stem cells support or suppress tumor growth?[J]. Stem Cells, 2011, 29(1): 11-19.
[18] Chien J, Kuang R, Landen C, et al. Platinum-sensitive recurrence in ovarian cancer: the role of tumor microenvironment[J]. Front Oncol, 2013, 3: 251.
[19] Kwee RM, Kwee TC. Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer[J]. World J Gastroenterol, 2014, 20(7): 1650-1656.
[1] ZHAO Canbin, SHAO Jiang, GUAN Donghui, QIN Ying, DING Qiang, GUO Liang, WANG Weiwei, CHEN Wei, YAN Xiaolong, ZENG Ping. Mechanism of luteolin regulating Wnt/β-catenin signal pathway in inflammatory microenvironment to promote chondrogenic differentiation of bone marrow mesenchymal stem cells [J]. Journal of Shandong University (Health Sciences), 2025, 63(7): 11-22.
[2] ZHANG Jie, ZHAO Yinghui, DONG Yaqi, LI Juan, LI Peilong, DU Lutao. Role of GPR133 gene methylation in predicting lymph node metastasis in early gastric cancer [J]. Journal of Shandong University (Health Sciences), 2025, 63(3): 76-84.
[3] CHEN Wenliang, WANG Huanhuan, HAO Jinjin, GONG Rui, ZHAO Qiang, ZHANG Fei, GAO Lei, DONG Jingxun. The role of lncRNA PVT1 in prognostic assessment and malignant progression of gastric cancer: a study based on nomogram model and functional cellular experiments [J]. Journal of Shandong University (Health Sciences), 2025, 63(10): 61-71.
[4] GUO Zhenjiang, WANG Ning, ZHAO Guangyuan, DU Liqiang, CUI Zhaobo, LIU Fangzhen. Development of preoperative models for predicting positive esophageal margin in proximal gastric cancer based on machine learning [J]. Journal of Shandong University (Health Sciences), 2024, 62(7): 78-83.
[5] LIU Haixia, HUANGFU Shasha, SANG Xiaoyu, CUI Dongqing, BI Jianzhong, WANG Ping. Effects of mesenchymal stem cells on ferroptosis in experimental autoimmune encephalomyelitis mice [J]. Journal of Shandong University (Health Sciences), 2024, 62(6): 1-8.
[6] SHEN Feifei, LI Dong, LIU Linghong, JU Xiuli. Umbilical cord mesenchymal stem cells sheets treated by small intestinal submucosa promote wound healing [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 68-77.
[7] BAI Xiaoliang, SUN Panpan, WANG Hongli, GONG Shunzhi, SUN Yunqi, SHU Meng, QI Xiaoliang. Animal experiment of medical thoracoscopic splanchnotomy [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 9-13.
[8] GUO Xin, MENG Jun, ZHENG Shiliang, DONG Xiuhong. Correlation between frailty and body composition in elderly patients with gastric cancer [J]. Journal of Shandong University (Health Sciences), 2024, 62(4): 40-47.
[9] YAN Xiaolong, QIN Ying, SHAO Jiang, CHEN Dongfeng, GUAN Donghui, ZHAO Canbin. Mechanism of curcumin regulating bone formation via the Wnt/β-catenin signaling pathway [J]. Journal of Shandong University (Health Sciences), 2024, 62(10): 76-86.
[10] SUN Jingguo, ZHU Wenshuai, LU Yi, MA Xiaoli, JIA Yanfei. Effects of Helicobacter pylori infection on m6A level in gastric cancer cells and its mechanism [J]. Journal of Shandong University (Health Sciences), 2023, 61(9): 10-18.
[11] FAN Rong, LI Binbin, MA Xiaoli, WANG Yunshan, JIA Yanfei. Expressions and clinical significance of DEC2 and HIF-2α in gastric cancer [J]. Journal of Shandong University (Health Sciences), 2023, 61(7): 12-18.
[12] WANG Zan, XU Xiaohan, ZHANG Yu, QU Yemin, WANG Mingyi, CHEN Ai. Effects of Helicobacter pylori infection on glycolysis of gastric cancer cells [J]. Journal of Shandong University (Health Sciences), 2023, 61(2): 16-24.
[13] WANG Cheng, ZHANG Shuhui, YAN Na, MENG Linlin, CHEN Liangzhi, LIU Qinghua. Mechanism of umbilical cord mesenchymal stem cells treating bleomycin-induced pulmonary interstitial fibrosis in mice [J]. Journal of Shandong University (Health Sciences), 2023, 61(10): 17-22.
[14] FU Jia, WANG Lulu, HU Shuai, CHEN Zheping, LIU Dongyi, LI Qingsong, LU Guodong, ZHANG He, ZHAO Xin, FENG Chang. Effects of different approaches of quadrates lumborum block on postoperative recovery of patients undergoing radical gastrectomy [J]. Journal of Shandong University (Health Sciences), 2022, 60(8): 50-57.
[15] BAO Shuqing, YANG Mingyue, LIU Duanrui, WANG Yunshan, JIA Yanfei. Role of NOX4 in ROS induction by Helicobacter pylori in gastric cancer cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(6): 19-25.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!